Patterns of Use of Belatacept: Analysis of Data From the Collaborative Transplant Study

NCT01476943 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 72392

Last updated 2018-05-04

No results posted yet for this study

Summary

The primary purpose is to describe the pattern of Belatacept use at the time of transplant and up to three years post-transplantation for all Belatacept treated patients.

Conditions

  • Transplantation, Organ

Sponsors & Collaborators

Principal Investigators

  • Bristol-Myers Squibb · Bristol-Myers Squibb

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2018-04-30
Completion
2018-04-30

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01476943 on ClinicalTrials.gov